CVS Stock Analysis

Aetna's Medical Loss Ratio (MLR). The percentage of premiums paid out as medical claims. Is the most important CVS metric for traders. MLR above 90% signals Aetna is paying out more than it collected in premiums, which destroys insurance profitability. MLR stabilization below 87% is the catalyst that would signal insurance segment recovery and drive CVS multiple re-expansion.

CVS's 5%+ dividend yield attracts income investors who provide price support at levels where the yield reaches 5.5-6%. The key risk is dividend sustainability. CVS maintains the dividend but free cash flow coverage has tightened due to debt from the Aetna and Oak Street acquisitions. Monitor FCF-to-dividend coverage ratio each quarter for sustainability confirmation.

CVS has traded at depressed RSI levels due to its insurance struggles. RSI below 32 with the dividend yield above 5.5% and the MLR showing sequential improvement has historically marked contrarian entry points where risk-reward tilts favorably. The stock requires patience. Turnarounds in insurance businesses typically take 4-6 quarters to fully reflect in earnings.

CVS's acquisition of Oak Street Health (value-based primary care clinics) is the long-term strategic bet. Owning primary care doctors who can steer patients toward CVS pharmacies and Aetna insurance plans. Oak Street's ability to reduce hospitalizations for its Medicare Advantage patients is the key test of the integrated care model's financial viability over 2-3 years.